Skip to main content

Table 1 The reported cases of Lyme Optic neuritis

From: Characteristics of Lyme optic neuritis: a case report of Lyme associated bilateral optic neuritis and systematic review of the literature

Cases

Age/Sex

Tick Bite

Erythema Migrans

Signs and Symptoms

Fundus

Imaging/Testing

Treatment

Treatment outcome

Cruz, et al. (2020) [18]

48/M

Does not recall

Unreported

1. Blurry vision OD

2. Inferior visual field defect

3. RAPD OD

4. Photopsia

1. Pale optic disc

2. Edema of inferior quadrant OD

3. Hyperemia and diffuse edema OS

MRI: unremarkable

VEP: delayed bilaterally

VF: generalized deficit on the right eye and a left inferior scotoma

Ceftriaxone

Improved, lost to follow up due to patient relocation

Jha, et al. (2018) [19]

46/F

Does not recall

Unreported

1. Progressive blurry vision > 3 wks.

2. Upper respiratory symptoms

3. Paresthesia

4. Nausea

5. Weakness

6. Bilateral lower extremities paresthesia

1. Bilateral optic head edema

2. Hyperemia

3. Optic disc edema

MRI: nonspecific white matter hyperintensities

VF: Cecocentral defects OU

Doxycycline

Patient did not return for follow up

Wang, et al.(2017) [20]

50/F

Does not recall

Pruritic rash on neck, chest, and right lower extremities

1. Right sided headache

2. Unspecified eye pain

3. Blurry vision OD

1. Optic head edema OD

MRI: enhancement of right optic nerve

Ceftriaxone

Methylprednisolone

Improved in symptoms

MRI shows resolution of findings

Burakgazi and Henderson (2016) [21]

59/F

Does not recall

Shoulders extending to midback, part of chest, left shoulder and right cheek

1. Blurry vision OD for 3–4 wks.

2. Fatigue and generalized joint pain

1. Optic head edema OD

MRI: unremarkable

VF: unspecified visual field defect

VA: 20/30 OD, 20/20 OS

Doxycycline

Improved visual deficits and symptoms

Tzoukeva, et al. (2014) [22]

42/F

Does not recall

Absence

1. Progressive blurry vision OS

2. Painful ocular movement

3. Left RAPD

4. Decreased color vision

Unremarkable

MRI: typical lesion characteristics of MS

Methylprednisolone

Medaxone

Cefprozil

Normalized

Qureshi, et al. (2016) [23]

43/M

Does not recall

unreported

1. Headache

2. Paresthesia

3. Nuchal rigidity

4. Kernig and Brudzinski sign

5. Seizure episodes

1. Posterior uveitis

2. Bilateral papillitis

MRI: diffuse hyperintensities involving supra and infratemporal cortical sulci consistent with diffuse leptomeningoencephalitis

Doxycycline

Ketorolac

Normalized

McVeigh and Vakros (2012) [24]

48/M

Denies recent bites, but had sustained bites previously

Absence

1. Bilateral loss of visual acuity

2. Painful ocular movements

3. Photophobia

4. Visual distortion

5. Ataxia

6. Headache

1. Uveitis

2. Bilateral disc swelling

3. Splinter hemorrhage OD

Unspecified

Oral Steroid

Ceftriaxone

Doxycycline

Amoxicillin

Normalized (Mild pallor of the left disc)

Blanc, et al.(2010) [25]

63/F

Yes

Unreported

1. Blurry vision OD

2. Headache

3. Arthralgia

Unspecified

MRI: 3 nonspecific lesions on T2 FLAIR and T2 weighted

VEP: delayed bilaterally

VA: 20/200 OD

Ceftriaxone

Visual acuity improved to 20/80

Blanc, et al.(2010) [25]

48/F

Yes

Denies

1. Arthralgia

2. Headache

3. Blurry vision

1. Bilateral papillitis

MRI: 2 nonspecific subcortical Flair lesions in left frontal lobe (< 3 mm in diameter)

VA: 20/100 OS

Ceftriaxone

Methylprednisolone

Visual acuity improved to 20/20

Santino, et al. (2009) [26]

33/M

Unspecified

Unspecified

1. Right central scotoma

2. Blurry vision

1. Bilateral papillitis

VA: 4/10 OD 10/10 OS

Methylprednisolone

Ceftriaxone

Visual acuity improved to 10/10 OU

Krim, et al. (2007) [27]

67/M

Yes

Right arm

1. Fatigue

2. Myalgia

3. Neck radiculopathy

4. Facial weakness

5. Ptosis

6. Diplopia

7. Fever

8. Peripheral right facial palsy

9. Right arm paresis

10. Retrobulbar pain

11. Diminished color perception OD

1. Bilateral uveitis

MRI: unremarkable

VEP: delayed OD

VF: central scotoma OD

VA: 5/10 OD 8/10 OS

Ceftriaxone

Corticotherapy

Neurological symptoms resolved, and visual acuity improved to 10/10 OU

  1. MRI Magnetic resonance imaging, VA Visual acuity, VEP Visual evoked potential, VF Visual field